Triplet Therapeutics Funding: $59M Raised, Series A (2019)
Triplet Therapeutics is based in Cambridge, Mass.. It has raised $59M in total funding. Latest round: Series A.
Triplet Therapeutics funding overview
Triplet Therapeutics is based in Cambridge, Mass.. Triplet Therapeutics has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2019. The round record for Triplet Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Atlas Venture, MPM Capital, Pfizer Ventures U.S. LLC, Invus, Partners Innovation Fund, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Triplet Therapeutics funding
How much has Triplet Therapeutics raised?
Triplet Therapeutics has raised $59M in total disclosed funding across the rounds on record.
Who has invested in Triplet Therapeutics?
Atlas Venture, MPM Capital, Pfizer Ventures U.S. LLC, Invus, Partners Innovation Fund, Alexandria Venture Investments are named among the investors backing Triplet Therapeutics.
What was the latest Triplet Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2019.
Where is Triplet Therapeutics based?
Triplet Therapeutics is based in Cambridge, Mass..
When did Triplet Therapeutics last raise?
The last disclosed Triplet Therapeutics round closed in December 2019 at Series A.
Every Triplet Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
